Fees, Snags in Russia Drive Off Trial Sponsors

Clinical Trials Advisor
A A
Costly local clinical trials required to register both novel and generic drugs in Russia are discouraging clinical trials in that country, according to the Russia-based Association of Clinical Trials Organizations (ACTO).

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00